The use of decomposition methods in real‐world treatment benefits evaluation for patients with type 2 diabetes initiating different injectable therapies: Findings from the INITIATOR study

by | May 14, 2019 | Endocrine, Publication

Abstract Authors: Brekke L, Buysman E, Grabner M, Ke X, Xie L, Baser O, Wei W Background: Determining characteristics of patients likely to benefit from a particular treatment could help physicians set personalized targets. Objectives: To use decomposition...